pharma · Chronic obstructive pulmonary disease (COPD) · Partial Epilepsy in Children and Adolescents
Bial Portela &
Bial Portela & Companhia S.A.
Bial Portela & patent portfolio — 3 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- EU
- Programs
- 7
- Drugs
- 7
- Patents
- 3
Bial Portela & patents
3 pharmaceutical patents indexed for Bial Portela &. 0 expire within 24 months.
Bial Portela & has 3 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does Bial Portela & have?
3 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Bial Portela & patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.